You searched for "PRP"
Dry eye disease treatments come to the fore at 100%
Guidance on setting up, or enhancing, a Dry Eye disease clinic within the practice will be freely available from OSA members exhibiting at 100% Optical: 1–3 March. The ability to diagnose and treat a major irritation for many is winning...OrCam MyEye – innovative sight assistance (Part 1)
For Jun/Jul 20201 and Aug/Sep 2021 we have a two-part review (see Part 2 here) of an innovative piece of sight impairment technology. The device is called a MyEye, made by OrCam. I was given the opportunity to use the...Envision Glasses – a different take on a sight impairment wearable (part 1)
In recent issues we reviewed the OrCam MyEye Pro, a glasses mounted mobile device that can assist sight impaired users. This time we are taking a look at the Envision Glasses, a comparable device that takes a different approach (see...Ambient scribes: The silent revolution
Clinical practice is in the midst of a profound digital transformation with a new wave of technology gaining increasing prominence: ambient scribes. These AI-powered tools streamline documentation by converting doctor–patient conversations into structured clinical notes in near real time. Healthcare...UKISCRS Cornea & Cataract Day 2026
United Kingdom & Ireland Society of Cataract & Refractce Surgeons Cornea & Cataract Day 2026Online submissions open for NCC contact lens congress
Online submissions for a collaborative research symposium to be held as part of Europe’s biggest eye health conference are now open.Updated Guidance for Professional Practice published by College of Optometrists
The College of Optometrists has today (11 December) published updated Guidance for Professional Practice for optometrists, including new sections.Teams start preparing for Optoversity Challenge 2025
Out of the Box Optic’s Optoversity Challenge – the exciting student competition and fundraiser for Vision Care for Homeless People – has opened the 2025 registration. Optometry schools are invited to propose a team for this easy-to-enter challenge which brings...
Fingolimod: ocular adverse effects
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....
